Conmed (CNMD) Tops Q1 EPS by 6c, Raises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.11 +1.12%
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Selling and administrative expense: 79.01M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.66, $0.06 better than the analyst estimate of $0.60. Revenue for the quarter came in at $295.5 million versus the consensus estimate of $266.67 million.
GUIDANCE:
Conmed sees FY2023 revenue of $1.21-1.25 billion, versus the consensus of $1.19 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Upstart Holdings (UPST) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
